These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19211285)

  • 1. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency.
    Wilson JM
    Mol Genet Metab; 2009 Apr; 96(4):151-7. PubMed ID: 19211285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public trust and research a decade later: what have we learned since Jesse Gelsinger's death?
    Yarborough M; Sharp RR
    Mol Genet Metab; 2009 May; 97(1):4-5. PubMed ID: 19285443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
    Raper SE; Yudkoff M; Chirmule N; Gao GP; Nunes F; Haskal ZJ; Furth EE; Propert KJ; Robinson MB; Magosin S; Simoes H; Speicher L; Hughes J; Tazelaar J; Wivel NA; Wilson JM; Batshaw ML
    Hum Gene Ther; 2002 Jan; 13(1):163-75. PubMed ID: 11779420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.
    Wilson JM; Shchelochkov OA; Gallagher RC; Batshaw ML
    Mol Genet Metab; 2012 Feb; 105(2):263-5. PubMed ID: 22129577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.
    Wang L; Morizono H; Lin J; Bell P; Jones D; McMenamin D; Yu H; Batshaw ML; Wilson JM
    Mol Genet Metab; 2012 Feb; 105(2):203-11. PubMed ID: 22133298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD).
    Batshaw ML; Wilson JM; Raper S; Yudkoff M; Robinson MB
    Hum Gene Ther; 1999 Sep; 10(14):2419-37. PubMed ID: 10515461
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
    Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
    Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel liver findings in ornithine transcarbamylase deficiency due to Xp11.4-p21.1 microdeletion.
    Gallant NM; Gui D; Lassman CR; Yong WH; Teitell M; Mandelker D; Lorey F; Martinez-Agosto JA; Quintero-Rivera F
    Gene; 2015 Feb; 556(2):249-53. PubMed ID: 25434494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.
    Prieve MG; Harvie P; Monahan SD; Roy D; Li AG; Blevins TL; Paschal AE; Waldheim M; Bell EC; Galperin A; Ella-Menye JR; Houston ME
    Mol Ther; 2018 Mar; 26(3):801-813. PubMed ID: 29433939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-therapy trials must proceed with caution.
    Nature; 2016 Jun; 534(7609):590. PubMed ID: 27357758
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy death prompts review of adenovirus vector.
    Marshall E
    Science; 1999 Dec; 286(5448):2244-5. PubMed ID: 10636774
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy under cloud.
    Lancet; 2000 Jan; 355(9201):329. PubMed ID: 10665545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of clinical features, metabolic profiling and gene mutations of patients with ornithine transcarbamylase deficiency].
    Wang Y; Liu X; Wu H; Liu H; Wang C; He X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):148-51. PubMed ID: 24711021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ornithine transcarbamylase deficiency and pancreatitis.
    Anadiotis G; Ierardi-Curto L; Kaplan PB; Berry GT
    J Pediatr; 2001 Jan; 138(1):123-4. PubMed ID: 11148526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency.
    Quintero-Rivera F; Deignan JL; Peredo J; Grody WW; Crandall B; Sims M; Cederbaum SD
    Mol Genet Metab; 2010 Dec; 101(4):413-6. PubMed ID: 20817516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripartum management of two parturients with ornithine transcarbamylase deficiency.
    Ituk U; Constantinescu OC; Allen TK; Small MJ; Habib AS
    Int J Obstet Anesth; 2012 Jan; 21(1):90-3. PubMed ID: 22138526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
    Raper SE; Chirmule N; Lee FS; Wivel NA; Bagg A; Gao GP; Wilson JM; Batshaw ML
    Mol Genet Metab; 2003; 80(1-2):148-58. PubMed ID: 14567964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death but one unintended consequence of gene-therapy trial.
    Sibbald B
    CMAJ; 2001 May; 164(11):1612. PubMed ID: 11402803
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperammonaemia type II as one of the congenital urea cycle defects].
    Ciara E
    Med Wieku Rozwoj; 1999; 3(1):83-95. PubMed ID: 10910641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].
    Chen Z; Wen P; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):565-9. PubMed ID: 25297582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.